Valley Fever Vaccine Development Act - Requires the Secretary of Health and Human Resources, acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants for research toward the development of a vaccine against coccidioidomycosis (commonly known as Valley Fever).
[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5416 Introduced in House (IH)]
109th CONGRESS
2d Session
H. R. 5416
To provide for grants to conduct research toward the development of a
vaccine against Valley Fever.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 18, 2006
Mr. Thomas introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To provide for grants to conduct research toward the development of a
vaccine against Valley Fever.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Valley Fever Vaccine Development
Act''.
SEC. 2. GRANTS FOR RESEARCH ON VACCINE AGAINST VALLEY FEVER.
(a) In General.--In supporting research on the development of
vaccines against human diseases, the Secretary of Health and Human
Services, acting through the Director of the Centers for Disease
Control and Prevention, shall make grants for the purpose of conducting
research toward the development of a vaccine against coccidioidomycosis
(commonly known as Valley Fever).
(b) Sunset.--No grant may be made under subsection (a) on or after
October 1, 2012. The preceding sentence does not have any legal effect
on payments under grants for which amounts appropriated under
subsection (c) were obligated prior to such date.
(c) Authorization of Appropriations.--For the purpose of making
grants under subsection (a), there are authorized to be appropriated
such sums as may be necessary for each of the fiscal years 2007 through
2012.
<all>
Introduced in House
Introduced in House
Sponsor introductory remarks on measure. (CR E876-877)
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line